Evidence map›Paper›PMID 30987256›Full record

ReviewMolecules (Basel, Switzerland)2019

Lactoferrin in Aseptic and Septic Inflammation.

Maria Stefania Lepanto, Luigi Rosa, Rosalba Paesano, Piera Valenti, Antimo Cutone

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed, 1 pooled it
12.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 1 synthesis or guideline pooled it, 144 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Review
  8. Article
  9. Pathogenic and Protective Roles of Neutrophils inPathogens (Basel, Switzerland) · 2025
    Review
  10. Article
  11. Association of salivary lactoferrin,Frontiers in immunology · 2025
    Article
  12. Article
  13. Review
  14. Review
  15. ValpalfInternational journal of molecular sciences · 2024
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Maria Stefania LepantoDepartment of Public Health and Infectious Diseases, University of Rome La Sapienza, 00185 Rome, Italy. mariastefania.lepanto@uniroma1.it.
Luigi RosaDepartment of Public Health and Infectious Diseases, University of Rome La Sapienza, 00185 Rome, Italy. luigi.rosa@uniroma1.it.ORCID 0000-0002-1252-6080
Rosalba PaesanoMicrobo S.R.L., 00153 Rome, Italy. info@microbosrl.it.
Piera ValentiDepartment of Public Health and Infectious Diseases, University of Rome La Sapienza, 00185 Rome, Italy. piera.valenti@uniroma1.it.
Antimo CutoneDepartment of Public Health and Infectious Diseases, University of Rome La Sapienza, 00185 Rome, Italy. antimo.cutone@uniroma1.it.
Sapienza University of Rome · ITUniversity of Molise · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lactoferrin (Lf), a cationic glycoprotein able to chelate two ferric irons per molecule, is synthesized by exocrine glands and neutrophils. Since the first anti-microbial function attributed to Lf, several activities have been discovered, including the relevant anti-inflammatory one, especially associated to the down-regulation of pro-inflammatory cytokines, as IL-6. As high levels of IL-6 are involved in iron homeostasis disorders, Lf is emerging as a potent regulator of iron and inflammatory homeostasis. Here, the role of Lf against aseptic and septic inflammation has been reviewed. In particular, in the context of aseptic inflammation, as anemia of inflammation, preterm delivery, Alzheimer's disease and type 2 diabetes, Lf administration reduces local and/or systemic inflammation. Moreover, Lf oral administration, by decreasing serum IL-6, reverts iron homeostasis disorders. Regarding septic inflammation occurring in

Indexed as

AnemiaAnimalsAnti-Infective AgentsAnti-Inflammatory AgentsBiomarkersHumansInflammationIronLactoferrinSepsisAnti-Infective AgentsAnti-Inflammatory AgentsBiomarkersIronLactoferrinalzheimer’s diseaseanemia of inflammationChlamydia trachomatis infectioncystic fibrosisinflammationinflammatory bowel diseaseiron homeostasislactoferrinpreterm deliverytype 2 diabetes

Identifiers

PMID30987256
PMCPMC6480387
OpenAlexW2935579023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.